Figure 3.

MiR-429 expression was associated with chemo-response to 5-FU-based treatment in CRC patients. (A) MiR-429 levels were significantly higher in non-responding group than in responding group among CRC patients receiving 5-FU-based chemotherapy. (B) No significant difference was found of miR-429 level among different 5-FU-based chemotherapy methods. (C) ROC curve was drawn to explore the capacity of miR-429 in distinguishing responding and non-responding patients receiving 5-FU-based treatment.